Compare ASMB & HLLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | HLLY |
|---|---|---|
| Founded | 2005 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 414.7M | 493.2M |
| IPO Year | 2010 | N/A |
| Metric | ASMB | HLLY |
|---|---|---|
| Price | $26.22 | $4.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $43.40 | $4.43 |
| AVG Volume (30 Days) | 98.7K | ★ 667.3K |
| Earning Date | 03-19-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $37,191,000.00 | ★ $598,132,000.00 |
| Revenue This Year | $33.33 | $1.75 |
| Revenue Next Year | N/A | $5.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 31.30 | N/A |
| 52 Week Low | $7.75 | $1.60 |
| 52 Week High | $39.71 | $4.43 |
| Indicator | ASMB | HLLY |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 52.05 |
| Support Level | $25.47 | $4.01 |
| Resistance Level | $27.50 | $4.26 |
| Average True Range (ATR) | 1.75 | 0.15 |
| MACD | 0.23 | 0.01 |
| Stochastic Oscillator | 35.04 | 70.19 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.